Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-22-000130

Chief Executive Officer bought 141,000 shares at $0.35 ($49,703)

From the SEC's structured data for this filing

Trades in this filing

PELLETIER SAUNDRA L · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-27 Purchase : show line 1 in the form +141,000 $0.35 $49,703 236,722 D
Open-market purchases · 141,000 sh · avg $0.35 · $49,703
Loading xslF345X03/wf-form4_165400171064865.xml…